Global Glaucoma Surgery Devices Market by Type (Glaucoma Drainage, Implants & Stents, Glaucoma Laser Devices, Glaucoma Systems), by End User (Private Eye Clinics, Hospitals), by Geography - Analysis and Forecast to 2019

Glaucoma is the second most common cause of blindness worldwide, and the leading cause of bilateral, irreversible blindness. It is characterized by the relatively high Intraocular Pressure (IOP) as a result of impaired drainage of a fluid, known as aqueous humor, from the eye. Currently, the approved treatments for glaucoma include a pharmaceutical drug, glaucoma laser therapies, and surgical procedures. It is estimated that by 2020, 11 million individuals will be blind due to glaucoma and around 10% of the people suffering from eye disorders will experience loss of vision in spite of proper treatment. This demand for developing advanced and technologically effective surgical equipment has led to the growth of the  glaucoma surgery devices market, globally.

The global glaucoma surgery devices market is estimated to grow at a CAGR of 8.4% from 2014 to 2019. The growing aging population; increasing incidence of ocular disorders; and rising incidence of obesity and diabetes are the major factors driving the growth of the global glaucoma surgery device market. On the other hand, general lack of awareness among people about eye disorders is a major factor that may restrain the market growth in the coming years.

The North American region dominates the global market for glaucoma surgery devices, having accounted for a 7.8% share in 2014, followed by Europe. The Asian market  is expected to become a substantial market for glaucoma surgery devices in the foreseeable future, as it is expected to grow at comparatively the fastest CAGR during the forecast period of 2014 to 2019.

In-depth market share analysis, by revenue, of the top companies has also included in the report. These numbers have been arrived at based on key facts; annual financial information from SEC filings and annual reports; and interviews with industry experts and key opinion leaders such as CEOs, directors, and marketing executives. A detailed market share analysis of the major players in the global glaucoma surgery devices market has also been covered in this report.

The key players in the global glaucoma surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and Iridex Corporation (U.S.).

Table of Contents

1 Introduction (Page No. - 11)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 13)
    2.1 Integrated Ecosystem of Glaucoma Surgery Devices
    2.2 Arriving at the Glaucoma Surgery Devices  Size
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
           2.2.3 Macroindicator-Based Approach
    2.3 Assumptions

3 Executive Summary (Page No. - 20)

4 Market Overview (Page No. - 22)
    4.1 Introduction
    4.2 Glaucoma Surgery Device : Comparison With Parent Market
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics

5 Glaucoma Surgery Devices Market: By Type (Page No. - 26)
    5.1 Introduction
    5.2 Glaucoma Surgery Device : Type Comparison With Ophthalmology Surgery Devices Market
    5.3 Glaucoma Drainage Devices Market, By Geography
    5.4 Glaucoma Implants & Stents Market,  By Geography
    5.5 Glaucoma Laser Market, By Geography
    5.6 Glaucoma System Market, By Geography

6 Glaucoma Surgery Devices Market:  By End-User (Page No. - 33)
    6.1 Introduction
    6.2 Glaucoma Surgery Devices : End-User Comparison With Surgery Device Market
    6.3 Glaucoma Surgery Devices  in Private Eye Clinics, By Geography
    6.4 Glaucoma Surgery Devices  in Hospitals,  By Geography

7 Glaucoma Surgery Devices Market:  By Geography (Page No. - 38)
    7.1 Introduction
    7.2 North America Glaucoma Surgery Devices
           7.2.1 North America Glaucoma Surgery Devices By Type
           7.2.2 North America Glaucoma Surgery Devices By End-User
           7.2.3 North America Glaucoma Surgery Devices By Geography
    7.3 Europe Glaucoma Surgery Devices
           7.3.1 Europe Glaucoma Surgery Devices By Type
           7.3.2 Europe Glaucoma Surgery Devices  By End-User
           7.3.3 Europe Glaucoma Surgery Devices  By Geography
    7.4 Asia Glaucoma Surgery Devices
           7.4.1 Asia Glaucoma Surgery Devices  By Type
           7.4.2 Asia Glaucoma Surgery Devices  By End-User
           7.4.3 Asia Glaucoma Surgery Devices  By Geography

8 Glaucoma Surgery Devices Market: Competitive Landscape (Page No. - 52)
    8.1 Glaucoma Surgery Devices : Company Share Analysis
    8.2 Mergers & Acquisitions
    8.3 Expansions
    8.4 Joint Ventures/Collaborations
    8.5 New Technology/Product Development

9 Glaucoma Surgery Devices Market: By Company (Page No. - 56)
(Overview, Financials, Products & Services, Strategy, and Developments)*
    9.1 Alcon, Inc.
    9.2 Abbott Laboratories
    9.3 Carl Zeiss Meditec AG
    9.4 Ellex Medical Lasers Limited
    9.5 Lumenis Ltd.
    9.6 Iridex Corporation
    9.7 Nidek Co., Ltd.
*Details on Overview, Financials, Product & Services, Strategy, and Developments Might Not be Captured in Case of Unlisted Company

10 Appendix (Page No. - 76)
     10.1 Customization Options
             10.1.1 Product Analysis
             10.1.2 Surgeons’/Physicians’ Perception Analysis
     10.2 Related Reports
     10.3 Introducing RT: Real Time Market Intelligence
             10.3.1 RT Snapshots

List of Tables (42 Tables)

Table 1 Glaucoma Surgery Device Peer Market Size,  2014 (USD MN)
Table 2 Glaucoma Surgery Devices Market: Macro Indicators, By Geography, 2014 (USD MN)
Table 3 Glaucoma Surgery Devices Market: Comparison With Parent Market, 2013–2019 (USD MN)
Table 4 Glaucoma Surgery Devices Market: Drivers and Inhibitors
Table 5 Glaucoma Surgery Devices Market By Type,  2013-2019 (USD MN)
Table 6 Glaucoma Surgery Devices Market By End-User, 2013-2019 (USD MN)
Table 7 Glaucoma Surgery Devices Market By Geography, 2013-2019 (USD MN)
Table 8 Glaucoma Surgery Devices Market By Type,  2013-2019 (USD MN)
Table 9 Glaucoma Surgery Devices : Type Comparison With Parent Market, 2013–2019 (USD MN)
Table 10 Glaucoma Drainage Devices Market, By Geography, 2013–2019 (USD MN)
Table 11 Glaucoma Implants & Stents Market, By Geography, 2013-2019 (USD MN)
Table 12 Glaucoma Laser Market, By Geography,  2013-2019 (USD MN)
Table 13 Glaucoma System Market, By Geography,  2013-2019 (USD MN)
Table 14 Glaucoma Surgery Device  By End-User,  2013–2019 (USD MN)
Table 15 Glaucoma Surgery Device : End-User Comparison With Parent Market, 2013–2019 (USD MN)
Table 16 Glaucoma Surgery Device  in Private Eye Clinics, By Geography, 2013-2019 (USD MN)
Table 17 Glaucoma Surgery Device  in Hospitals,  By Geography, 2013-2019 (USD MN)
Table 18 Glaucoma Surgery Device Market By Geography,  2013-2019 (USD MN)
Table 19 North America Glaucoma Surgery Device  By Type, 2013-2019 (USD MN)
Table 20 North America Glaucoma Surgery Device  By End-User, 2013-2019 (USD MN)
Table 21 North America Glaucoma Surgery Device  By Geography, 2013-2019 (USD MN)
Table 22 Europe Glaucoma Surgery Device  By Type, 2013-2019 (USD MN)
Table 23 Europe Glaucoma Surgery Device  By End-User, 2013-2019 (USD MN)
Table 24 Europe Glaucoma Surgery Device  By Geography, 2013-2019 (USD MN)
Table 25 Asian Glaucoma Surgery Device By Type, 2013-2019 (USD MN)
Table 26 Asia Glaucoma Surgery Device By End-User, 2013-2019 (USD MN)
Table 27 Asia Glaucoma Surgery Device  By Geography, 2013-2019 (USD MN)
Table 28 Glaucoma Surgery Device : Company Share Analysis, 2014 (%)
Table 29 Glaucoma Surgery Device : Mergers & Acquisitions
Table 30 Glaucoma Surgery Device : Expansions
Table 31 Glaucoma Surgery Device : Joint Ventures/Collaborations
Table 32 Glaucoma Surgery Device : New Technology/Product Development
Table 33 Abbott Laboratories: Key Operations Data, 2012-2014 (USD MN)
Table 34 Abbott Laboratories: Key Financials, 2012-2014 (USD MN)
Table 35 Carl Zeiss Meditec Ag: Key Operations Data, 2012-2014 (USD MN)
Table 36 Carl Zeiss Meditec Ag: Key Financials, 2012-2014 (USD MN)
Table 37 Ellex Medical Lasers Limited: Key Operations Data, 2012-2014 (USD MN)
Table 38 Ellex Medical Lasers Limited: Key Financials, 2012-2014 (USD MN)
Table 39 Lumenis Ltd.: Key Operations Data, 2011-2013 (USD MN)
Table 40 Lumenis Ltd.: Key Financials, 2011-2013 (USD MN)
Table 41 Iridex Corporation: Key Operations Data, 2011-2013 (USD MN)
Table 42 Iridex Corporation: Key Financials, 2011-2013 (USD MN)

List of Figures (36 Figures)

Figure 1 Glaucoma Surgery Devices : Segmentation & Coverage
Figure 2 Glaucoma Surgery Devices : Integrated Ecosystem
Figure 3 Research Methodology
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macroindicator-Based Approach
Figure 7 Glaucoma Surgery Device Market Snapshot, 2014
Figure 8 Geographic Analysis: Glaucoma Surgery Device By Type, 2014 (USD MN)
Figure 9 Glaucoma Surgery Device By Type,  2014-2019 (USD MN)
Figure 10 Glaucoma Surgery Device : Type Comparison With Ophthalmology Surgery Devices Market, 2013–2019 (USD MN)
Figure 11 Glaucoma Drainage Devices Market, By Geography, 2013-2019 (USD MN)
Figure 12 Glaucoma Implants & Stents Market, By Geography, 2013-2019 (USD MN)
Figure 13 Glaucoma Laser Market, By Geography,  2013-2019 (USD MN)
Figure 14 Glaucoma System Market, By Geography,  2013-2019 (USD MN)
Figure 15 Glaucoma Surgery Device By End-User,  2014-2019 (USD MN)
Figure 16 Glaucoma Surgery Device : End-User Comparison With Ophthalmology Surgery Device Market,  2013–2019 (USD MN)
Figure 17 Glaucoma Surgery Device  in Private Eye Clinics, By Geography, 2013-2019 (USD MN)
Figure 18 Glaucoma Surgery Device  in Hospitals,  By Geography, 2013-2019 (USD MN)
Figure 19 North America Glaucoma Surgery Device  Overview, 2014 & 2019 (%)
Figure 20 North America Glaucoma Surgery Device  By Type, 2013-2019 (USD MN)
Figure 21 North America Glaucoma Surgery Device  By End-User, 2013-2019 (USD MN)
Figure 22 North America Glaucoma Surgery Device  By Geography, 2014-2019 (USD MN)
Figure 23 Europe Glaucoma Surgery Device  Overview, 2014 & 2019 (%)
Figure 24 Europe Glaucoma Surgery Device By Type,  2013-2019 (USD MN)
Figure 25 Europe Glaucoma Surgery Device  By End-User, 2013-2019 (USD MN)
Figure 26 Europe Glaucoma Surgery Device  By Geography, 2014-2019 (USD MN)
Figure 27 Asian Glaucoma Surgery Device  Overview, 2014 & 2019 (%)
Figure 28 Asia Glaucoma Surgery Device By Type,  2013-2019 (USD MN)
Figure 29 Asia Glaucoma Surgery Device By End-User, 2013-2019 (USD MN)
Figure 30 Asia Glaucoma Surgery Device By Geography, 2014-2019 (USD MN)
Figure 31 Glaucoma Surgery Device : Company Share Analysis, 2014 (%)
Figure 32 Abbott Laboratories: Revenue Mix, 2014 (%)
Figure 33 Carl Zeiss Meditec Ag: Revenue Mix, 2014 (%)
Figure 34 Ellex Medical Lasers Limited: Revenue Mix, 2014 (%)
Figure 35 Lumenis Ltd. Revenue Mix, 2013 (%)
Figure 36 Iridex Corporation: Geography Revenue Mix, 2013 (%)

This market research report categorizes the Glaucoma surgery devices market in terms of types, namely glaucoma drainage devices, glaucoma implants & stents, glaucoma lasers, and glaucoma systems. The study is based on primary and secondary research, and analyzes the market based on product sales and competitive scenario. It also studies and analyzes the trends and opportunities in the market.

The first line of therapy for glaucoma begins with pharmacological intervention, followed by glaucoma laser therapy, and surgery (if necessary). In some cases, some glaucoma patients may require all three treatment options. The pharmacological approach has been challenged as being less effective, when compared to the others. Surgery is considered for traumatic glaucoma, infantile/juvenile glaucoma, silicone glaucoma, neovascular glaucoma, and some cases of uveitis.

The global glaucoma surgery devices market was valued at $210.3 million in 2014, and is projected to reach $314.3 million by 2019, at a CAGR of 8.4% during the period under consideration. Among the types considered in the market analysis, the glaucoma drainage devices segment dominated the overall market in 2014, and is estimated to reach a market size of $175.4 million by 2019.

The North American region accounted for the largest share of the total global glaucoma surgery devices market in 2014, and is forecast to reach a market value of $138.3 million by 2019, at a CAGR of 7.8% during the given forecast period. Globally, the Asian market is expected to be the fastest-growing market in the global glaucoma surgery devices market. The Asian market was valued at $45.3 million in 2014 and is expected to reach $74.2 million by 2019, at the fastest CAGR of 10.4% from 2014 to 2019. The market in Asia is driven by both established and emerging markets. The success in more developed regions countries such as Japan continues to support opportunities for growth in the Asian region. Similar opportunities exist in several developing regions, specifically India, China, and South Korea.

The increasing prevalence of eye-related disorders, such as macular degeneration and diabetic retinopathy; the aging population worldwide; and the rising government initiatives towards healthcare infrastructure in developing countries are among the key driving factors for the growth of the global glaucoma surgery device market.

The aging population factor is a significant driver for the growth of the global market, boosting sales for products directed at addressing diseases related to eyes, and emphasizing early intervention through diagnosis and treatments. The global population will continue to grow and age; older people are expected to account for 20% to 25% of each region's total population by 2020. This suggests a steady market path for the glaucoma surgery devices in the coming years.

Based on end-users, the global market has been categorized into private eye clinics, hospitals, and other end-users, in which the private eye clinics segment led the glaucoma surgery device market in 2014, and is projected to reach a market size of $173.7 million by 2019.

The key players in the global glaucoma surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and Iridex Corporation (U.S.).